[HTML][HTML] Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
SE Litwin, CA East - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Of the various medical therapies for heart failure (HF), sacubitril/valsartan is a first-in-class
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
S Litwin, C East - Frontiers in Cardiovascular Medicine, 2022 - europepmc.org
Of the various medical therapies for heart failure (HF), sacubitril/valsartan is a first-in-class
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
[HTML][HTML] Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
SE Litwin, CA East - Frontiers in Cardiovascular Medicine, 2022 - ncbi.nlm.nih.gov
Of the various medical therapies for heart failure (HF), sacubitril/valsartan is a first-in-class
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
SE Litwin, CA East - Frontiers in cardiovascular medicine, 2022 - pubmed.ncbi.nlm.nih.gov
Of the various medical therapies for heart failure (HF), sacubitril/valsartan is a first-in-class
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure.
SE Litwin, CA East - Frontiers in Cardiovascular Medicine, 2022 - europepmc.org
Of the various medical therapies for heart failure (HF), sacubitril/valsartan is a first-in-class
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …
angiotensin receptor-neprilysin inhibitor that combines sacubitril, a pro-drug that is further …